Cancer Immunology, Immunotherapy

ISSN: 0340-7004
eISSN: 1432-0851
Publisher: Springer Verlag (Germany)

Publications (18)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study (2024) Beckmann M, Schlüter J, Erdmann M, Kramer R, Cunningham S, Hackstein H, Zimmermann R, Heinzerling L Journal article Neutrophils seeking new neighbors: radiotherapy affects the cellular framework and the spatial organization in a murine breast cancer model (2024) Reichardt C, Munoz Becerra M, Rius Rigau AR, Rückert M, Fietkau R, Schett G, Gaipl U, et al. Journal article Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections (2023) Schmitt C, Hoefsmit EP, Fangmeier T, Kramer N, Kabakci C, Vera González J, Versluis JM, et al. Journal article Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib (2023) Häselbarth L, Karow A, Mentz K, Böttcher M, Roche-Lancaster O, Krumbholz M, Jitschin R, et al. Journal article Checkpoint-inhibitor induced Polyserositis with Edema (2022) Zierold S, Akcetin LS, Gresser E, Maier AM, Koenig A, Kramer R, Theurich S, et al. Journal article Clinical determinants of long-term survival in metastatic uveal melanoma (2021) Koch E, Petzold A, Wessely A, Dippel E, Erdmann M, Heinzerling L, Hohberger B, et al. Journal article International Regensburg Center for Interventional Immunology (RCI) symposium on “Synthetic immunology and environment-adapted redirection of T cells”, 17–18 July, 2019, Regensburg, Germany (2020) Beckhove P, Edinger M, Feuerer M, Gattinoni L, Abken H Journal article Immune biological rationales for the design of combined radio- and immunotherapies (2020) Hader M, Frey B, Fietkau R, Hecht M, Gaipl U Journal article, Review article T cell engineering for adoptive T cell therapy: safety and receptor avidity (2019) D'Ippolito E, Schober K, Nauerth M, Busch DH Journal article, Review article Targeting tumor-associated acidity in cancer immunotherapy (2018) Lacroix R, Rozeman EA, Kreutz M, Renner K, Blank CU Journal article, Review article